SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-006577 to NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) (CIK 0001500198) (NMTC)

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) (CIK 0001500198)
Date: June 7, 2024 · CIK: 0001500198 · Accession: 0000000000-24-006577

AI Filing Summary & Sentiment

File numbers found in text: 333-279871

Date
June 7, 2024
Author
Not clearly detected
Form
UPLOAD
Company
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) (CIK 0001500198)

Letter

United States securities and exchange commission logo June 7, 2024 David Rosa Chief Executive Officer NeuroOne Medical Technologies Corporation 7599 Anagram Dr. Eden Prairie, MN 55344 Re:NeuroOne Medical Technologies Corporation Registration Statement on Form S-3 Filed May 31, 2024 File No. 333-279871 Dear David Rosa: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Benjamin Richie at 202-551-7857 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Emily Johns

Show Raw Text
United States securities and exchange commission logo
June 7, 2024
David Rosa
Chief Executive Officer
NeuroOne Medical Technologies Corporation
7599 Anagram Dr.
Eden Prairie, MN 55344
Re:NeuroOne Medical Technologies Corporation
Registration Statement on Form S-3
Filed May 31, 2024
File No. 333-279871
Dear David Rosa:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Benjamin Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Emily Johns